My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 186

    1.

    Narrative review: pharmacotherapy for chronic heart failure: evidence from recent clinical trials.

    Yan AT, Yan RT, Liu PP.

    Ann Intern Med. 2005 Jan 18;142(2):132-45. Review.PMID: 15657162 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.

    Dulin BR, Krum H.

    Curr Opin Cardiol. 2006 Jul;21(4):393-9. Review.PMID: 16755210 [PubMed - indexed for MEDLINE]Related articles

    3.

    Angiotensin-converting enzyme inhibitors and angiotensin II type I receptor blockers in the management of congestive heart failure patients: what have we learned from recent clinical trials?

    Mielniczuk L, Stevenson LW.

    Curr Opin Cardiol. 2005 Jul;20(4):250-5. Review.PMID: 15956818 [PubMed - indexed for MEDLINE]Related articles

    4.

    Treatment of chronic heart failure in long-term care facilities: implications of recent heart failure guidelines recommendations.

    Ahmed A.

    Arch Gerontol Geriatr. 2003 Sep-Oct;37(2):131-7. Review.PMID: 12888226 [PubMed - indexed for MEDLINE]Related articles

    5.

    Improving clinical outcomes with drug treatment in heart failure: what have trials taught?

    Konstam MA.

    Am J Cardiol. 2003 Mar 20;91(6A):9D-14D. Review.PMID: 12670637 [PubMed - indexed for MEDLINE]Related articles

    6.

    New therapeutic agents for the management of congestive heart failure.

    Feldman AM.

    Curr Opin Cardiol. 1994 May;9(3):301-4. Review.PMID: 7914112 [PubMed - indexed for MEDLINE]Related articles

    7.

    Pharmacotherapy of congestive heart failure in elderly patients.

    Burger PC, Brunner-La Rocca H.

    J Cardiovasc Pharmacol Ther. 2005 Jun;10(2):85-94. Review.PMID: 15965559 [PubMed - indexed for MEDLINE]Related articles

    8.

    Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.

    [No authors listed]

    Prescrire Int. 2005 Oct;14(79):180-6.PMID: 16285075 [PubMed - indexed for MEDLINE]Related articles

    9.

    Pharmacologic advances in long-term heart failure management.

    Pfeffer MA.

    Am Heart Hosp J. 2004 Fall;2(4 Suppl 1):15-20. Review.PMID: 15539971 [PubMed - indexed for MEDLINE]Related articles

    10.

    Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.

    Jorde UP.

    Cardiol Rev. 2006 Mar-Apr;14(2):81-7. Review.PMID: 16493245 [PubMed - indexed for MEDLINE]Related articles

    11.

    Controversies in the use of beta blockers in heart failure.

    Chavey WE 2nd, Bleske BE, Nicklas JM.

    Congest Heart Fail. 2003 Sep-Oct;9(5):255-62. Review.PMID: 14564144 [PubMed - indexed for MEDLINE]Related articles

    12.

    An approach to heart failure and diabetes mellitus.

    Fonarow GC.

    Am J Cardiol. 2005 Aug 22;96(4A):47E-52E. Review.PMID: 16098844 [PubMed - indexed for MEDLINE]Related articles

    13.

    Management of chronic heart failure: an old disease with a new face.

    Prendergast HM, Bunney EB.

    Emerg Med Australas. 2005 Apr;17(2):143-51. Review.PMID: 15796729 [PubMed - indexed for MEDLINE]Related articles

    14.

    Implications of heart failure drug trials: COMET, CHARM, EPHESUS.

    Hiestand B, Abraham WT.

    Rev Cardiovasc Med. 2005;6 Suppl 2:S4-11. Review.PMID: 15891699 [PubMed - indexed for MEDLINE]Related articles

    15.

    Reducing the risks of sudden death and heart failure post myocardial infarction: utility of optimized pharmacotherapy.

    Sackner-Bernstein J.

    Clin Cardiol. 2005 Nov;28(11 Suppl 1):I19-27. Review.PMID: 16450809 [PubMed - indexed for MEDLINE]Related articles

    16.

    Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.

    Tokmakova M, Solomon SD.

    Curr Opin Cardiol. 2006 Jul;21(4):268-72. Review.PMID: 16755193 [PubMed - indexed for MEDLINE]Related articles

    17.

    Neurohormones and heart failure: the importance of aldosterone.

    Odedra K, Ferro A.

    Int J Clin Pract. 2006 Jul;60(7):835-46. Review.PMID: 16846401 [PubMed - indexed for MEDLINE]Related articles

    18.

    Are symptoms the most important target for therapy in chronic heart failure?

    Cleland JG.

    Prog Cardiovasc Dis. 1998 Jul-Aug;41(1 Suppl 1):59-64. Review.PMID: 9715824 [PubMed - indexed for MEDLINE]Related articles

    19.

    Improving outcomes in chronic heart failure.

    Komajda M.

    Drugs Today (Barc). 2006 Dec;42 Suppl C:29-36. Review.PMID: 17245479 [PubMed - indexed for MEDLINE]Related articles

    20.

    Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure.

    Lenzen MJ, Boersma E, Reimer WJ, Balk AH, Komajda M, Swedberg K, Follath F, Jimenez-Navarro M, Simoons ML, Cleland JG.

    Eur Heart J. 2005 Dec;26(24):2706-13. Epub 2005 Sep 23.PMID: 16183692 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity